{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T19:38:52Z","timestamp":1766086732320},"reference-count":43,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1517\/14712598.2012.704908","type":"journal-article","created":{"date-parts":[[2012,7,10]],"date-time":"2012-07-10T12:00:57Z","timestamp":1341921657000},"page":"1251-1263","source":"Crossref","is-referenced-by-count":33,"title":["Clinical development of IMOJEV\u00ae\u2014a recombinant Japanese encephalitis chimeric vaccine (JE-CV)"],"prefix":"10.1517","volume":"12","author":[{"given":"Mohan Babu","family":"Appaiahgari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudhanshu","family":"Vrati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2012,7,9]]},"reference":[{"key":"CIT0001","unstructured":"Gubler D, Kuno G, Markoff L. In: Fields BN, Knipe DM, Howley PM. Flaviviruses, Japanese encephalitis virus. 530, Walnut Street, Philadelphia, PA 19106, USA: Wolters Kluwer Health\/Lippincott Williams & Wilkins; 2007. p. 1185-90"},{"key":"CIT0002","first-page":"337","volume":"73","author":"World Health Organization","year":"1998","journal-title":"Wkly Epidemiol Rec"},{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/oxfordjournals.epirev.a036087","volume":"14","author":"Vaughn DW","year":"1992","journal-title":"Epidemiol Rev"},{"key":"CIT0004","doi-asserted-by":"crossref","first-page":"719","DOI":"10.4269\/ajtmh.1959.8.719","volume":"8","author":"Buescher EL","year":"1959","journal-title":"Am J Trop Med Hyg"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.mi.40.100186.002143"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-59403-8_2"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.5.3091-3098.2003"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-67-3-591"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2005.05.023"},{"key":"CIT0010","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.4049\/jimmunol.141.10.3606","volume":"141","author":"Kimura-Kuroda J","year":"1988","journal-title":"J Immunol"},{"key":"CIT0011","first-page":"312","volume":"26","author":"Takegami T","year":"1982","journal-title":"Acta Virol"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198809083191004"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66156-9"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(97)00020-0"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)92707-9"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.2001.056008804.x"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-76-2-409"},{"key":"CIT0018","first-page":"242","volume":"80","author":"World Health Organization","year":"2005","journal-title":"Wkly Epidemiol Rec"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05967-0"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67567-8"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.01.021"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.04.052"},{"key":"CIT0023","first-page":"52","author":"Mehta P","year":"2009","journal-title":"Bioventures Global Health"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.09.098"},{"key":"CIT0025","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1128\/JVI.73.4.3095-3101.1999","volume":"73","author":"Chambers TJ","year":"1999","journal-title":"J Virol"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1097\/01.qco.0000178823.28585.ad"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1586\/erv.10.139"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.4161\/hv.1.3.1797"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.4.1742-1751.2000"},{"key":"CIT0030","unstructured":"Guideline on quality, non-clinical and clinical aspects of live recombinant viral vectored vaccines. 7, Westferry Circus, Canary Wharf, London, E14 4HB, UK: European Medical Agency, Committee for Medicinal Products for Human Use; 2010. p. 1-14"},{"key":"CIT0031","unstructured":"Note for Guidance on the quality, preclinical and clinical aspects of gene transfer medicinal products. 7, Westferry Circus, Canary Wharf, London, E14 4HB, UK: The European agency for the Evaluation of Medicinal Products, Evaluation of Medicines for Human use; 2001. p. 1-33"},{"key":"CIT0032","unstructured":"Australian Public Assessment report for Japanese Encephalitis Chimeric Virus. PO Box 100, Woden ACT 2606, Australia: Australian Government, Department of Health and Ageing; 2010. p. 1-77"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.03.027"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1999.9695"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00487-3"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02273-08"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3181f68e9c"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00457-1"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1086\/378356"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.4161\/hv.6.12.13057"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.4161\/hv.6.11.12854"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.09.035"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.2.1032-1038.2004"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14712598.2012.704908","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T17:06:30Z","timestamp":1714151190000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14712598.2012.704908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,9]]},"references-count":43,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2012,8,14]]},"published-print":{"date-parts":[[2012,9]]}},"alternative-id":["10.1517\/14712598.2012.704908"],"URL":"https:\/\/doi.org\/10.1517\/14712598.2012.704908","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,9]]}}}